Linscomb & Williams, Inc. Baxter International Inc Transaction History

Linscomb & Williams, Inc.

  • $1.97 Billion
  • Q4 2024

A detailed history of Linscomb & Williams, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 35,904 shares of BAX stock, worth $1.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
35,904
Previous 33,730 6.45%
Holding current value
$1.12 Million
Previous $1.28 Million 18.28%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$28.63 - $37.84 $62,241 - $82,264
2,174 Added 6.45%
35,904 $1.05 Million
Q3 2024

Nov 06, 2024
BUY
$32.85 - $40.26 $24,177 - $29,631
736 Added 2.23%
33,730 $1.28 Million
Q2 2024

Aug 07, 2024
BUY
$32.87 - $43.55 $23,863 - $31,617
726 Added 2.25%
32,994 $1.1 Million
Q1 2024

May 14, 2024
BUY
$37.88 - $43.77 $19,091 - $22,060
504 Added 1.59%
32,268 $1.38 Million
Q4 2023

Feb 06, 2024
BUY
$31.71 - $38.95 $15,791 - $19,397
498 Added 1.59%
31,764 $1.23 Million
Q3 2023

Oct 10, 2023
BUY
$37.32 - $49.29 $16,308 - $21,539
437 Added 1.42%
31,266 $1.18 Million
Q2 2023

Aug 09, 2023
BUY
$39.98 - $47.68 $439 - $524
11 Added 0.04%
30,829 $1.4 Million
Q1 2023

May 11, 2023
SELL
$37.58 - $52.57 $38,669 - $54,094
-1,029 Reduced 3.23%
30,818 $1.25 Million
Q4 2022

Feb 14, 2023
BUY
$49.7 - $57.71 $116,298 - $135,041
2,340 Added 7.93%
31,847 $1.62 Million
Q3 2022

Nov 09, 2022
SELL
$53.86 - $66.8 $4,793 - $5,945
-89 Reduced 0.3%
29,507 $1.59 Million
Q2 2022

Aug 15, 2022
SELL
$63.83 - $80.0 $10,468 - $13,120
-164 Reduced 0.55%
29,596 $1.9 Million
Q1 2022

May 17, 2022
BUY
$76.85 - $89.45 $80,846 - $94,101
1,052 Added 3.66%
29,760 $2.31 Million
Q4 2021

Feb 10, 2022
BUY
$74.57 - $87.19 $67,634 - $79,081
907 Added 3.26%
28,708 $2.46 Million
Q3 2021

Nov 03, 2021
BUY
$73.77 - $83.61 $75,540 - $85,616
1,024 Added 3.82%
27,801 $2.24 Million
Q2 2021

Aug 10, 2021
BUY
$80.5 - $88.01 $96,036 - $104,995
1,193 Added 4.66%
26,777 $2.16 Million
Q1 2021

May 12, 2021
BUY
$76.38 - $86.03 $26,427 - $29,766
346 Added 1.37%
25,584 $2.16 Million
Q4 2020

Feb 11, 2021
BUY
$75.39 - $82.36 $85,416 - $93,313
1,133 Added 4.7%
25,238 $2.03 Million
Q3 2020

Nov 13, 2020
BUY
$78.33 - $90.73 $91,332 - $105,791
1,166 Added 5.08%
24,105 $1.94 Million
Q2 2020

Aug 11, 2020
BUY
$78.66 - $94.14 $414,144 - $495,647
5,265 Added 29.79%
22,939 $1.98 Million
Q1 2020

May 11, 2020
BUY
$71.57 - $93.3 $107,855 - $140,603
1,507 Added 9.32%
17,674 $1.44 Million
Q4 2019

Feb 13, 2020
BUY
$76.7 - $88.45 $17,794 - $20,520
232 Added 1.46%
16,167 $1.35 Million
Q3 2019

Nov 08, 2019
BUY
$81.4 - $89.78 $12,779 - $14,095
157 Added 1.0%
15,935 $1.39 Million
Q2 2019

Aug 06, 2019
BUY
$73.44 - $82.41 $440 - $494
6 Added 0.04%
15,778 $1.29 Million
Q1 2019

May 09, 2019
BUY
$64.48 - $81.31 $9,478 - $11,952
147 Added 0.94%
15,772 $1.28 Million
Q4 2018

Feb 08, 2019
SELL
$61.45 - $77.8 $22,613 - $28,630
-368 Reduced 2.3%
15,625 $1.03 Million
Q3 2018

Nov 08, 2018
SELL
$70.71 - $77.75 $52,537 - $57,768
-743 Reduced 4.44%
15,993 $1.23 Million
Q2 2018

Aug 07, 2018
SELL
$63.43 - $75.41 $15,413 - $18,324
-243 Reduced 1.43%
16,736 $1.24 Million
Q1 2018

May 04, 2018
SELL
$62.56 - $72.26 $21,583 - $24,929
-345 Reduced 1.99%
16,979 $1.1 Million
Q4 2017

Feb 02, 2018
SELL
$61.45 - $66.05 $53,830 - $57,859
-876 Reduced 4.81%
17,324 $1.12 Million
Q3 2017

Oct 27, 2017
BUY
$59.5 - $64.61 $1.08 Million - $1.18 Million
18,200
18,200 $1.14 Million

Others Institutions Holding BAX

# of Institutions
936
Shares Held
468M
Call Options Held
2.57M
Put Options Held
3.29M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $15.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Linscomb & Williams, Inc. Portfolio

Follow Linscomb & Williams, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email